BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 32746954)

  • 1. Principles for deliberative processes in health technology assessment.
    Bond K; Stiffell R; Ollendorf DA
    Int J Technol Assess Health Care; 2020 Aug; ():1-8. PubMed ID: 32746954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designing and Implementing Deliberative Processes for Health Technology Assessment: A Good Practices Report of a Joint HTAi/ISPOR Task Force.
    Oortwijn W; Husereau D; Abelson J; Barasa E; Bayani DD; Santos VC; Culyer A; Facey K; Grainger D; Kieslich K; Ollendorf D; Pichon-Riviere A; Sandman L; Strammiello V; Teerawattananon Y
    Int J Technol Assess Health Care; 2022 Jun; 38(1):e37. PubMed ID: 35656641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designing and Implementing Deliberative Processes for Health Technology Assessment: A Good Practices Report of a Joint HTAi/ISPOR Task Force.
    Oortwijn W; Husereau D; Abelson J; Barasa E; Bayani DD; Canuto Santos V; Culyer A; Facey K; Grainger D; Kieslich K; Ollendorf D; Pichon-Riviere A; Sandman L; Strammiello V; Teerawattananon Y
    Value Health; 2022 Jun; 25(6):869-886. PubMed ID: 35667778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value Assessment Frameworks for HTA Agencies: The Organization of Evidence-Informed Deliberative Processes.
    Baltussen R; Jansen MPM; Bijlmakers L; Grutters J; Kluytmans A; Reuzel RP; Tummers M; der Wilt GJV
    Value Health; 2017 Feb; 20(2):256-260. PubMed ID: 28237205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deliberative processes in health technology assessment of medicines: the case of Spain.
    Pinilla-Dominguez P; Pinilla-Dominguez J
    Int J Technol Assess Health Care; 2023 Jul; 39(1):e50. PubMed ID: 37403252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deliberative processes in decision making informed by health technology assessment in Latin America.
    Alcaraz A; Pichon-Riviere A; García-Martí S; Alfie V; Augustovski F; Castro H
    Int J Technol Assess Health Care; 2022 Dec; 38(1):e86. PubMed ID: 36524558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicriteria decision analysis (MCDA) for health technology assessment: the Queensland Health experience.
    Howard S; Scott IA; Ju H; McQueen L; Scuffham PA
    Aust Health Rev; 2019 Oct; 43(5):591-599. PubMed ID: 30205873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence-Informed Deliberative Processes for HTA Around the Globe: Exploring the Next Frontiers of HTA and Best Practices Comment on "Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe".
    Gopinathan U; Ottersen T; Cyr PR; Chalkidou K
    Int J Health Policy Manag; 2021 Mar; 10(4):232-236. PubMed ID: 32772012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strengthening international patient advocacy perspectives on patient involvement in HTA within the HTAi Patient and Citizen Involvement Interest Group - Commentary.
    Wale JL; Scott AM; Bertelsen N; Meade N;
    Res Involv Engagem; 2017; 3():3. PubMed ID: 29062528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence-Informed Deliberative Processes for Health Benefit Package Design - Part II: A Practical Guide.
    Oortwijn W; Jansen M; Baltussen R
    Int J Health Policy Manag; 2022 Oct; 11(10):2327-2336. PubMed ID: 34923809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence-Informed Deliberative Processes for Legitimate Health Benefit Package Design - Part I: Conceptual Framework.
    Baltussen R; Jansen M; Oortwijn W
    Int J Health Policy Manag; 2022 Oct; 11(10):2319-2326. PubMed ID: 34923808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards Integrated Health Technology Assessment for Improving Decision Making in Selected Countries.
    Oortwijn W; Determann D; Schiffers K; Tan SS; van der Tuin J
    Value Health; 2017 Sep; 20(8):1121-1130. PubMed ID: 28964444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addressing Health System Values in Health Technology Assessment: The Use of Evidence-Informed Deliberative Processes.
    Oortwijn W; Klein P
    Int J Technol Assess Health Care; 2019; 35(2):82-84. PubMed ID: 30957730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deliberative Processes by Health Technology Assessment Agencies: A Reflection on Legitimacy, Values and Patient and Public Involvement Comment on "Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe".
    Goetghebeur M; Cellier M
    Int J Health Policy Manag; 2021 Mar; 10(4):228-231. PubMed ID: 32610794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value and impact of health technology assessment: discussions and recommendations from the 2023 Health Technology Assessment International Global Policy Forum.
    Trowman R; Migliore A; Ollendorf DA
    Int J Technol Assess Health Care; 2023 Dec; 39(1):e75. PubMed ID: 38130164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges and Opportunities for Deliberative Processes for Healthcare Decision-Making Comment on "Evidence-Informed Deliberative Processes for Health Benefit Package Design - Part II: A Practical Guide".
    Bond K
    Int J Health Policy Manag; 2023; 12():7458. PubMed ID: 35988028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fair Processes for Priority Setting: Putting Theory into Practice Comment on "Expanded HTA: Enhancing Fairness and Legitimacy".
    Jansen MP; Helderman JK; Boer B; Baltussen R
    Int J Health Policy Manag; 2017 Jan; 6(1):43-47. PubMed ID: 28005541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of evidence-informed deliberative processes in health technology assessment in low- and middle-income countries.
    Oortwijn W; van Oosterhout S; Kapiriri L
    Int J Technol Assess Health Care; 2020 Jul; ():1-5. PubMed ID: 32715993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementing evidence-informed deliberative processes in health technology assessment: a low income country perspective.
    Kapiriri L; Baltussen R; Oortwijn W
    Int J Technol Assess Health Care; 2020; 36(1):29-33. PubMed ID: 31944173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic literature review on the implicit factors influencing the HTA deliberative process in Europe.
    Monleón C; Späth HM; Crespo C; Dussart C; Toumi M
    J Mark Access Health Policy; 2022; 10(1):2094047. PubMed ID: 35811835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.